<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03649399</url>
  </required_header>
  <id_info>
    <org_study_id>419/17</org_study_id>
    <nct_id>NCT03649399</nct_id>
  </id_info>
  <brief_title>Sonographic Detection of Prophylactic Pancreatic Stents</brief_title>
  <official_title>Sonographic Detection of Pancreatic Stents Placed for Prophylaxis of Post-ERCP Pancreatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Retention of pancreatic stents for prophylaxis of post-ERCP pancreatitis (PEP) is
      assessed by abdominal x-ray according to international Guidelines. The current study aimed to
      analyze whether prophylactic pancreatic stents can be detected by transdermal ultrasound to
      save the x-ray examination.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pancreatitis is the most common complication of endoscopic retrograde
      cholangiopancreatography (ERCP). Several pharmacologic and procedure-related measurements
      have been established for post-ERCP pancreatitis (PEP) prophylaxis one being the placement of
      pancreatic duct stents in patients with high risk for PEP. The beneficial role of pancreatic
      stenting in the prophylaxis of PEP was demonstrated in large meta-analyses. The used stents
      have a high potential of self dislodgment, retained stents have to be removed endoscopically
      after 5-10 days. For evaluation of spontaneous stent passage abdominal x-ray ist used and
      accordingly retained stents removed. The current study aimed to analyze whether prophylactic
      pancreatic stents can be detected by transdermal ultrasound to save the x-ray examination.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">April 21, 2020</completion_date>
  <primary_completion_date type="Actual">April 21, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Positive predictive value of the sonographic detection of pancreatic stents</measure>
    <time_frame>5-10 days after stent placement</time_frame>
    <description>Test whether the stents can be detected reliably by ultrasound</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Negative predictive value of the sonographic detection of pancreatic stents</measure>
    <time_frame>5-10 days after stent placement</time_frame>
    <description>Test whether and why the stents cannot be detected reliably by ultrasound</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Pancreatitis</condition>
  <condition>Stent Dislodgement</condition>
  <arm_group>
    <arm_group_label>Patients with pancreatic stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>abdominal ultrasound and x-ray for stent detection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Abdominal ultrasound</intervention_name>
    <description>Abdominal ultrasound for detection of the pancreatic stent</description>
    <arm_group_label>Patients with pancreatic stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient after pancreatic stent placement for prophylaxis of post-ERCP pancreatitis

          -  age 18-79

          -  signed informed consent

        Exclusion Criteria:

          -  any disease that rules out study participation

          -  patient not legally competent to sign informed consent

          -  chronic pancreatis as indication for pancreatic stenting
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mireen Friedrich-Rust, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Frankfurt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum der J.W. Goethe-Universit√§t</name>
      <address>
        <city>Frankfurt am Main</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>August 25, 2018</study_first_submitted>
  <study_first_submitted_qc>August 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2018</study_first_posted>
  <last_update_submitted>April 21, 2020</last_update_submitted>
  <last_update_submitted_qc>April 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Georg Dultz</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

